Search by Name

Select Practice Area

Sector

We feature 1574 specialists in this practice area.

Select Location

We identify specialists in 48 countries.

Featured Articles
Analysis
Experts
Firms

Featured Articles: Life Sciences

Q&A with Adam Nagorski

Emergo Group Inc – General Counsel and Vice President, Global Legal Affairs

Adam Nagorski speaks to us about his role within Emergo Group, qualities he looks for when instructing external counsel, and the future of the global medical device market.

Renewed Hope for Defendants in Certification Motions of Medical Products Class Actions

By Peter J Pliszka of Fasken Martineau DuMoulin

During the relatively short history of class proceedings in Canada, developers and manufacturers of medical devices and pharmaceuticals (medical products) have found themselves at the receiving end of a significant number of class action claims. To date, the main battleground in respect of these claims has been the certification motion, a preliminary step in which the court assesses whether or not a given claim should proceed as a class action.

Lessons in Compliance – What Medical Devices Manufacturers Can Learn From Recent EU Enforcement Landscape

By Josefine Sommer and Maurits Lugard of Sidley Austin

Medical devices manufacturers are braced for the overhaul of the EU Medical Devices Directives. New Regulations, which are closer to final adoption than ever (although not quite there yet), are expected to clarify the regulation of medical devices in Europe – at least once the delegated and implementing acts have been put in place.

Indirect Infringement in Pharmaceutical Patent Cases in Spain

By Manuel Lobato and Marco Yago of Bird & Bird

This article intends to briefly describe two elements of indirect infringement of pharmaceutical patents that have been discussed in Spanish Courts, namely, products with a skinny label and the principle of territoriality in the article 51.1 Spanish Patent Act.

Serving It Up Sufficiently

By Nicola Dagg of Allen & Overy

The requirement that a patent specification must disclose the invention in a manner that is “clear enough and complete enough for it to be performed by a person skilled in the art” (UK Patents Act/EPC) represents a significant source of commercial uncertainty for patentees.

Page

2
3
4
5
6
Next
Last →

8 pages Search

Analysis: Life Sciences

Life Sciences 2019

We are delighted to present WWL: Life Sciences 2019, which covers 1,067 lawyers from 443 firms worldwide.

Below we highlight the leading firms overall in our research this year. Many of the firms below earn individual listings across multiple chapters, although most show one clear area of strength. Hogan Lovells once again receives the most listings, with 41 in this edition, an increase of two from 2018, continuing to demonstrate strong product liability and transactional practices at the heart of its offering. Bird & Bird and Sidley Austin also perform well, each receiving 30 listings, with the former's patent litigation offering excelling this year, and the latter's expertise on the regulatory side particularly evident.

Individual practice area charts can be found in the respective chapter analyses.

Life Sciences: Patent Litigation 2019

This chapter sees 403 practitioners highlighted for their work in the field. European firms dominate the listings this year, with Bristows, Bird & Bird and Hoyng Rokh Monegier all performing strongly. In North America, Canadian and US firms vie for pre-eminence in our research, with several outfits performing exceptionally well. In Australia, meanwhile, Allens stands out for its depth of expertise in the field.

Life Sciences: Product Liability 2019

This year’s guide to the leading practitioners in the life sciences - product liability space sees 297 individuals highlighted for their impressive work across a range of mandates arising from medical device, pharmaceutical and biotech-related issues.

Life Sciences: Regulatory 2019

This year’s guide sees 314 individuals highlighted across 42 jurisdictions for their work on regulatory matters in the life sciences space.

Life Sciences: Transactional 2019

Our research into the global life sciences transactional legal market sees 208 lawyers highlighted for their work in the field.

Life Sciences 2018: Regulatory Analysis

This year, our research identifies 314 standout regulatory law experts with a proven track record advising major clients in the life sciences sector. Those featured are highly skilled at providing advice and innovative solutions on matters ranging from product development, approval and manufacture to pricing, market safety and customs rules.

Life Sciences 2018: Transactional Analysis

In this section, we highlight 218 transactional lawyers who have been selected for their outstanding work in the life sciences sector. Those included are the world’s leading experts when it comes to the corporate side of life sciences practices, and focus on a wide range of matters including mergers and acquisitions, IPOs, securities and venture capital transactions, outsourcing, and investment agreements and joint ventures.

Life Sciences 2018: Trends & Conclusions

Life sciences lawyers have had another busy year, reporting record-high levels of work across the board. For many life sciences and healthcare companies, 2017 was a particularly challenging year. Increased regulatory scrutiny, soaring R&D costs and heightened pricing pressures, coupled with the turbulent economic climate brought about by political changes, have led to fierce market competition. As a result, the legal community has experienced a surge in both contentious and non-contentious work in the sector, spurred on by the continued advancement of both major players and innovative start-ups. We spoke to some of the world’s most prominent practitioners in the life sciences space to examine some of the main trends affecting the market at the moment.

Life Sciences 2018

We are delighted to present WWL: Life Sciences 2018, which covers 1,047 lawyers from 420 firms worldwide.

Below we highlight the leading firms overall in our research this year. All but one of the firms below boast individual listings across multiple chapters, although most show one clear area of strength. Hogan Lovells stands out as the top firm in our research, with 39 listings in total and with particularly strong product liability and transactional practices at the heart of its offering. Sidley Austin, Bird & Bird and Covington & Burling all also perform well, with 33, 27 and 25 listings respectively.

Individual practice area charts can be found in the appropriate chapter analyses.

Life Sciences 2018: Patent Litigation Analysis

This chapter identifies 399 leading lights in the field of patent litigation from across 211 firms worldwide. Those included are well versed at handling patent disputes across a range of industry sectors, including pharmaceuticals, biotechnology and medical devices.

Life Sciences

Featured Articles: Life Sciences

Analysis: Life Sciences

All Experts in Life Sciences (Listed Alphabetically)